Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
Financial Results:
Themis Medicare Ltd reported Revenues for Q1FY24 of ₹97.00 Crores up from ₹94.00 Crore year on year, a rise of 3.19%.
Total Expenses for Q1FY24 of ₹80.00 Crores up from ₹78.00 Crores year on year, a rise of 2.56%.
Consolidated Net Profit of ₹18.00 Crores up 5.88% from ₹17.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹19.77, up 4.55% from ₹18.91 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.